Adagio Medical has closed a $19 million private placement to advance its Ultra-Low Temperature Cryoablation technology for ventricular tachycardia, led by healthcare-focused institutional investors.
Adagio Medical Holdings announced the closing of a $19 million private placement to accelerate the development and commercialization of its ULTC systems for ventricular tachycardia. Proceeds will support crucial submissions and clinical studies, public awareness, and manufacturing scale-up. Adagio's technology is engineered for safety and efficacy in cardiac ablation, already used in over 350 patients. The funding allows the company to strengthen operations and extend its financial runway.
Who to call at Adagio Medical, and when
A new round usually means Adagio Medical is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Adagio Medical raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Adagio Medical, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Adagio Medical
Location
26051 MERIT CIRCLE
Laguna Hills, California, United States
About
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLASTM Cryoablation System which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT U.S. IDE Pivotal Study.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adagio Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.